The increase in antibiotic-resistant microorganisms has driven a search for new antibiotic targets and novel antimicrobial agents. A large number of different antibiotics target bacterial ribosomal subunit formation. Several specific ribonucleases are important in the processing of rRNA during subunit biogenesis. This work demonstrates that the ribonuclease inhibitor, vanadyl ribonucleoside complex (VRC), can inhibit RNases involved in ribosomal subunit formation. The ribosomal subunit synthesis rate was significantly decreased and ribosomal RNA from the subunit precursors was degraded. VRC had no inhibitory effect on translation. VRC also potentiated the inhibitory effects of an aminoglycoside and a macrolide antibiotic
Virginiamycin S is an inhibitor of protein synthesis in vivo. In this paper we show by equilibrium d...
Nine structurally similar macrolide antibiotics were tested at a concentration of 0.5 μg/ml for thei...
The use of antibiotics has revolutionized medicine, greatly improving our capacity to save millions ...
The increase in antibiotic-resistant microorganisms has driven a search for new antibiotic targets a...
Objectives: The discovery of new antibiotic targets is important to stem the increase in antibiotic ...
The development of microbial resistance to practically all currently used antimicrobial agents has s...
The bacterial ribosome is an important target for many antimicrobial agents. Aminoglycoside antibiot...
The continuing increase in antibiotic-resistant pathogenic bacterial has stimulated research on the ...
This article describes 20 years of research that investigated a second novel target for ribosomal an...
A substantial number of antimicrobial agents target some activity of the bacterial ribosome for inhi...
The translational functions of the bacterial ribosome are the target for a large number of antimicro...
The aminoglycoside antibiotic hygromycin B was examined in Escherichia coli cells for inhibitory eff...
Erythromycin and other macrolide antibiotics have been examined for their effects on ribosome assemb...
The inhibition of bacterial ribosomal subunit formation is a novel target for translational inhibito...
Several antibiotics that prevent translation by binding to ribosomal subunits have been shown to als...
Virginiamycin S is an inhibitor of protein synthesis in vivo. In this paper we show by equilibrium d...
Nine structurally similar macrolide antibiotics were tested at a concentration of 0.5 μg/ml for thei...
The use of antibiotics has revolutionized medicine, greatly improving our capacity to save millions ...
The increase in antibiotic-resistant microorganisms has driven a search for new antibiotic targets a...
Objectives: The discovery of new antibiotic targets is important to stem the increase in antibiotic ...
The development of microbial resistance to practically all currently used antimicrobial agents has s...
The bacterial ribosome is an important target for many antimicrobial agents. Aminoglycoside antibiot...
The continuing increase in antibiotic-resistant pathogenic bacterial has stimulated research on the ...
This article describes 20 years of research that investigated a second novel target for ribosomal an...
A substantial number of antimicrobial agents target some activity of the bacterial ribosome for inhi...
The translational functions of the bacterial ribosome are the target for a large number of antimicro...
The aminoglycoside antibiotic hygromycin B was examined in Escherichia coli cells for inhibitory eff...
Erythromycin and other macrolide antibiotics have been examined for their effects on ribosome assemb...
The inhibition of bacterial ribosomal subunit formation is a novel target for translational inhibito...
Several antibiotics that prevent translation by binding to ribosomal subunits have been shown to als...
Virginiamycin S is an inhibitor of protein synthesis in vivo. In this paper we show by equilibrium d...
Nine structurally similar macrolide antibiotics were tested at a concentration of 0.5 μg/ml for thei...
The use of antibiotics has revolutionized medicine, greatly improving our capacity to save millions ...